Home › Attention Deficit Hyperactivity Disorder › Kentucky
Attention Deficit Hyperactivity Disorder clinical trials in Kentucky
3 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Kentucky.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Bardstown
- Clinical Research Site, Owensboro
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 6, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Bardstown
- Clinical Research Site, Owensboro
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Nov 6, 2026 · NCT07717892Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Kentucky Pediatric/Adult Research, Bardstown
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Oct 5, 2026 · NCT04781140From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.